Glopolon

thenexttrade99
Into stock/options trading and doing whatever it takes to be less stressed.. also a family guy fan which helps.

Jeerio
Professional strategist and author. Unprofessional at virtually everything else.

adamfeuerstein
I am a senior columnist at TheStreet, covering the biotechnology and drug sectors.

klosterman_53

TraderMED
Student doctor. Stock, futures, & options trader. Technical analyst of broad market, big movers, & biotech stocks. **Not Financial Advice. Opinion only**

MedDevicesDaily

BloombergNews
This is the official page for Bloomberg News headlines. Follow us on Twitter for top global business news of the day.

natesadeghi
Co-founder of PhoneFive. Healthcare investor for 14 years. Possibilian. Dad. Former rower, pretend athlete. Click the bit.ly link above to set up a call with me.

LTbioinvestor

seemacnbc
CNBC Reporter. Financial journalist.

LifeSciAdvisors
LifeSci Advisors is a unique consultancy founded to provide comprehensive equity research, strategic counsel, customized marketing communications and investor relations services to our clients in the life-sciences.

bioworld

BioDueDiligence
Professional scientific skeptic and biotech/pharma commentator. Follow my writing on BiotechDueDiligence, HSP90 Central, SeekingAlpha, Chimera Research Group

behaviorgap
Real Name: Carl Richards. Goal: Trying to ask the right questions about money...using a Sharpie

BioStockAddict

biotech_trader

IPOtweet
Founded in 1991, Renaissance Capital is the global leader in providing institutional IPO research. The Firm maintains the FTSE Renaissance IPO Index Series and provides IPO-focused investment management services as advisor to the Global IPO Fund.

nexparadigm

Jaymo